MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
BMY — Bristol-Myers Squibb Co.
NYSEBristol-Myers Squibb Co.
$61.46
-0.94(-1.51%)
- O
- 62.20
- H
- 62.61
- L
- 61.25
- V
- 10.66M
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About BMY
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateJun 23, 1952
Employees32,500
Stock ExchangeNYSE
Ticker SymbolBMY
Websitehttps://www.bms.com
Key Financial Statistics
| Market Cap | $128.41B |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.91 - $81.44 |
| 52-Week Avg Volume | 6.46M |
| VWAP | $61.59 |
| Transactions | 112,734 |
| Total Recorded Bars | 13,695 days |